Throughout this medical market research, the publisher analyzed 46 infusion therapy companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of EU Infusion Therapy Device market analysis, each of the market segments is also available as stand-alone MedCore reports.
Markets Covered
EU Infusion Therapy Device Market Insights
The expansion of alternate care is expected to somewhat offset the negative impact caused by COVID-19 over the forecast period. Many healthcare markets are already trending towards alternate care since it relieves some of the strain that is placed on hospitals. During a global health pandemic, this becomes especially important.
Currently the standard of care for infusions in Europe is gravity drip infusion, administered through a gravity set. However, sales of pump sets have been growing faster and are growing in terms of share of total infusions performed.
Overall, the European infusion therapy device market was valued at €1 billion in 2019. This is expected to increase over the forecast period at a CAGR of 1.3% to reach €1.1 billion by 2026.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
While this MedSuite report contains all of EU Infusion Therapy Device market analysis, each of the market segments is also available as stand-alone MedCore reports.
Markets Covered
- Infusion Pump Market - MedCore
- Intravenous Set Market- MedCore
- Needleless Connector Market - MedCore
- Stopcock Market - MedCore
- Blood Transfusion Set Market - MedCore
EU Infusion Therapy Device Market Insights
The expansion of alternate care is expected to somewhat offset the negative impact caused by COVID-19 over the forecast period. Many healthcare markets are already trending towards alternate care since it relieves some of the strain that is placed on hospitals. During a global health pandemic, this becomes especially important.
Currently the standard of care for infusions in Europe is gravity drip infusion, administered through a gravity set. However, sales of pump sets have been growing faster and are growing in terms of share of total infusions performed.
Overall, the European infusion therapy device market was valued at €1 billion in 2019. This is expected to increase over the forecast period at a CAGR of 1.3% to reach €1.1 billion by 2026.
Report Regional Coverage
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux (Belgium, Netherlands, and Luxembourg)
- Scandinavia (Denmark, Finland, Norway, and Sweden)
- Switzerland
- Austria
- Portugal
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acromedical
- Applied Medical
- AMS Ltd. UK
- Aries
- B. Braun
- Baxter
- Becton Dickinson
- Benefis
- Bexen Medical
- Biolena
- BMS Critical Care
- BQ Plus
- C.V. Medica
- Cair
- Codan
- Crest Medical
- Fresenius Kabi
- Delta Med
- Didactic
- Doran
- Fannin
- Ferrari L. Medical Devices
- Hospital Services
- ICU Medical
- IMS Euro
- Intervene
- Kimal
- Klinicom
- Leventon
- Macropharm
- McKinley Medical
- Mediplus
- Medispo
- Micrel
- Moog
- Multimedia
- Poly Medicure
- Rays
- S.M.D.
- Sares
- Shermond
- Smiths Medical
- Terumo
- Vygon
- Walkmed
- Woo Young Medical
